Supplementary Table 2: Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase 3 safety study
收藏数据链接：
官方服务：
资源简介：
Supplementary Table 2. Tanezumab for Chronic Low Back Pain: A Long-term, Randomized, Celecoxib-Controlled, Japanese, Phase 3, Safety Study Summary of all-causality TEAEs through week 80 (treatment + follow-up period)
创建时间：
2021-11-18
